Close
Show

Clinical Trials

World Pharma Today clinical Trials covers all updates & latest in clinical trials news, Pharma clinical trial company news, clinical trials technology…

Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement to Develop MDT-637


Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered...

Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on...


Biogen Idec announced that the European Medicines Agency's Committee for Medicinal Products for Human...

Boehringer Ingelheim’s lead hepatitis C compound moves into phase III – the first within...


Boehringer Ingelheim announced the study outline for the pivotal Phase III clinical trials designed to...

Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in Parkinson’s Disease Levodopa-Induced Dyskinesia (PD-LID)


  Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today the initiation of a Phase IIa...

Adocia reports positive phase I clinical results on HinsBet(R), a fast-acting human insulin


Adocia, a privately-held biotechnology company specialized in regenerative medicine and in the treatment of chronic...

Infinity Initiates Phase 2 Trial of IPI-926 in Patients With Chondrosarcoma


Infinity Pharmaceuticals, Inc. announced the initiation of a randomized, double-blind Phase 2 clinical trial to...

NovaBay Pharmaceuticals Initiates Phase 2 Clinical Trial for the Treatment of Urinary Catheter


NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for...

GlaxoSmithKline and Human Genome Sciences announce publication of BLISS-52 phase lll study results


GlaxoSmithKline (GSK)  and Human Genome Sciences, Inc. announced publication of the BLISS-52 study of Benlysta®...

Plexxikon Initiates Phase 1 Clinical Trial for Oral Rheumatoid Arthritis Agent PLX5622


Plexxikon Inc. announced that dosing began in the first of two Phase 1 clinical trials...

Sanofi-aventis Reports Top-line Results from Phase III Study with BSI-201 in Metastatic Triple-Negative Breast...


Sanofi-aventis and its subsidiary, BiPar Sciences, announced that a randomized Phase III trial evaluating BSI-201...